Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Selenate, Sodium and Uridine Triacetate

Research Papers that Mention the Interaction

In vitro, sodium selenate reduced tau phosphorylation in human neuroblastoma cells and reversed the increase in tau phosphorylation induced by the PP2A inhibitor, okadaic acid.
Neurobiology of Disease  •  2012  |  View Paper
Acute treatment of either neuroblastoma cells or normal aged mice with sodium selenate rapidly reduced tau protein phosphorylation.
Journal of Clinical Neuroscience  •  2010  |  View Paper
Previous work by our group has shown sodium selenate upregulates the activity of protein phosphatase 2 in the brain, increasing the rate of tau dephosphorylation.
BMJ Open  •  2020  |  View Paper
Sodium selenate has been recently found to reduce tau hyperphosphorylation and NFTs formation, and to improve spatial learning and motor performance in AD mice.
PloS one  •  2014  |  View Paper
Sodium selenate up-regulates PP2A/PR55 and dephosphorylates tau , and may hold promise as a treatment in the mild brain injury setting.
Neuropharmacology  •  2016  |  View Paper
Here, we identify sodium selenate as a compound that reduces tau phosphorylation both in vitro and in vivo.
Taken together, sodium selenate mitigates tau pathology in several AD models, making it a promising lead compound for tau-targeted treatments of AD and related dementias.
Proceedings of the National Academy of Sciences  •  2010  |  View Paper